Daley, Michael D. & Greenberg, Julie S.. Demystifying pharmacogenomic implications for the anesthesia provider. Retrieved from https://doi.org/doi:10.7282/t3-156r-qn96
DescriptionPurpose of Project: The ultimate aim was that anesthesia providers gain more awareness about pharmacogenomics and seek to educate themselves further on the topic in order to themselves incorporate it into their anesthetic practice.
Methodology: This study will be a prospective, descriptive, multicohort design that will examine the impact of a didactic educational presentation with the use of a highly reliable survey set. There will be three times and settings where the pre-survey will be administered to an educationally diverse group of anesthesia providers, followed by the educational presentation. The subsequent post-survey evaluation will mimic the initial survey. This post-survey will provide statistically measurable, qualitative continuous, and categorical data as to the efficacy of the educational intervention.
Results: Complete data were gathered as assessed from 57 anesthesia providers consisting of CRNAs, SRNAs and physician anesthesiologists which revealed a positive correlation with enhanced education and the improved utilization of pharmacogenomics as an addition to daily preoperative care planning. Also noting a positive attitude about the utilization of pharmacogenomics 86% in anesthetic practice.
Implications for Practice: Improved understanding of pharmacogenomics testing by anesthesia providers would also advance the use of these reports in the perioperative setting to prevent adverse drug reactions, improve patient safety and satisfaction throughout the operative and recovery periods for elective to emergency procedures.